Related Experiment Videos
Hematologic and oncologic complications in the critically ill child.
The Yale Journal of Biology and Medicine
|March 1, 1984
Summary
Critically ill children may require intensive care for hematologic or oncologic complications. This review covers blood transfusion, hemostasis, and unique issues in sickling or malignant diseases.
Area of Science:
- Hematology
- Oncology
- Pediatric Intensive Care
Background:
- Hematologic and oncologic diseases can necessitate intensive care unit (ICU) admission for direct complications.
- Complications include sepsis, metabolic derangements, tumor compression, and disseminated coagulopathy.
- Hematologic issues also frequently arise in critically ill children with other conditions like trauma or infections.
Purpose of the Study:
- To review key hematologic issues relevant to critically ill children.
- To discuss topics with broad application in pediatric critical care, such as blood transfusion and hemostasis.
- To address specific hematologic problems in patients with sickling disorders or malignant diseases.
Main Methods:
- Literature review focusing on hematologic and oncologic complications in pediatric intensive care.
- Synthesis of information on blood transfusion and hemostasis.
- Discussion of unique challenges in patients with specific hematologic or oncologic conditions.
Main Results:
- Hematologic and oncologic conditions present unique management challenges in the ICU.
- Blood transfusion and hemostasis are critical areas for critically ill children.
- Sickling disorders and malignant diseases require specialized approaches to hematologic management.
Conclusions:
- Effective management of critically ill children with hematologic or oncologic diseases requires specialized knowledge.
- Understanding blood transfusion and hemostasis is crucial for broad application in pediatric critical care.
- Tailored strategies are necessary for managing hematologic complications in patients with sickling or malignant diseases.